Antithrombotic Therapy and Mortality Risk in Older Adults with Hip Fractures.

Objectives: Antithrombotic therapy, including antiplatelet therapy, direct oral anticoagulants (DOACs), and vitamin K antagonists (VKAs), is increasingly prescribed. These therapies pose complex challenges in patients with hip fracture due to risks of bleeding, risks of thromboembolism, and their potential role as markers of frailty. However, limited real-world evidence exists regarding their risks and benefits in this population.

The effects of in-hospital orthogeriatric care on health-related quality of life: a systematic review and meta-analysis.

Background: Orthogeriatric care has been shown to effectively reduce mortality and morbidity and has a potential impact on health-related quality of life (HRQoL). This systematic review and meta-analysis summarises the effects of orthogeriatric care on HRQoL in hip fracture patients.

Methods: The review protocol was registered in International Prospective Register of Systematic Reviews (PROSPERO): CRD42021206280.